Diptendu Sarkar✉
Department of Microbiology, Ramakrishna Mission Vidyamandira, Belur Math, Howrah-711202, West Bengal, India
Received: Oct 9, 2022/ Revised: Nov 11, 2022/ Accepted: Nov 14, 2022
(✉) Corresponding Author: diptendu81@gmail.com
Abstract
The Indian plant Moringa oleifera is found in tropical and subtropical climates across the globe. It is frequently cultivated for its embryonic seed pods and leaves, that are consumed as vegetables and also for herbal remedies. Using in silico computational techniques and three CYP450 enzymes, this study assessed the potential hepatoprotective effects of probable metabolites in watery M. oleifera leaf extracts. All quantities of aqueous M. oleifera leaf extract were subjected to several qualitative phytochemical analyses. The flavonoid galangin demonstrated the strongest interactions with the majority of cytochrome P450 enzymes in accordance with the predicted binding affinity, followed by caffeic acid. Galangin also outperformed the bulk of other known CYP450 enzyme inhibitors. These results suggest that the hepatoprotective effects of M. oleifera leaf extract on CYP450 may be due to galangin. In comparison to galangin and caffeine acid, two reference substances, 1H-indazole, and alpha-naphthoflavone, were shown to have energy values with all three receptors between -4.6 and -4.8. The in silico screening data showed that when docked to CYP1A2, CYP2E1, and CYP2D6, all compounds had a greater binding affinity. Therefore, additional studies are necessary to support these findings.
Keywords: CYP450 enzymes, Galangin, Enzyme inhibitors, Caffeine acid, Binding affinity
References
Alsenz, J., Steffen, H., Alex, R. (1998). Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharm Res. 15(3):423-8. doi: 10.1023/a:1011924314899.
Arooj, M., Sakkiah, S., Kim, S., Arulalapperumal, V., & Lee, K. W. (2013). A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors. PLoS One, 8(4), e63030.
Asrani, S.K., Devarbhavi, H., Eaton, J., Kamath, P.S. (2019). Burden of liver diseases in the world. J Hepatol. 70(1):151-71. doi: 10.1016/j.jhep.2018.09.014.
Au, J.S., Navarro, V.J., Rossi, S. (2011). Review article: Drug-induced liver injury—its pathophysiology and evolving diagnostic tools. Aliment Pharmacol Ther. 34(1):11-20. doi: 10.1111/j.1365-2036.2011.04674.x,
Azam, S. S., & Abbasi, S. W. (2013). Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theoretical Biology and Medical Modelling, 10(1), 1-16.
Balimane, P. V., Chong, S., & Morrison, R. A. (2000). Current methodologies used for evaluation of intestinal permeability and absorption. Journal of pharmacological and toxicological methods, 44(1), 301-312.
Basheer, L., Kerem, Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid Med Cell Longev. 015:854015. doi: 10.1155/2015/854015.
Beaulieu, D., & Ohemeng, K. A. (1999). Patents on bacterial tRNA synthetase inhibitors: January 1996 to March 1999. Expert Opinion on Therapeutic Patents, 9(8), 1021-1028.
Beeching, N. J., Fenech, M., & Houlihan, C. F. (2014). Ebola virus disease. BMJ 349: g7348.
Benet, L. Z., & Hoener, B. A. (2002). Changes in plasma protein binding have little clinical relevance. Clinical Pharmacology & Therapeutics, 71(3), 115-121.
Bissantz, C., Folkers, G., & Rognan, D. (2000). Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. Journal of medicinal chemistry, 43(25), 4759-4767.
Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron, 36(22), 3219-3228.
Grant, D.M. (1991). Detoxification pathways in the liver. J Inherit Metab Dis. 14(4):421-30. doi: 10.1007/BF01797915.
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999). MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening. Journal of pharmaceutical sciences, 88(1), 28-33.
Kerr, T. A., Davidson, N. O. (2012). Cholesterol and NAFLD: Renewed focus on an old villain. Hepatology (Baltimore, Md.); (v):56(5):1995.
Loprinzi, C. L., Barton, D. L., & Qin, R. (2011). Nonestrogenic management of hot flashes. Journal of Clinical Oncology, 29(29), 3842-3846.
Melo, A. P. S., França, E. B., Malta, D. C., Garcia, L. P., Mooney, M., Naghavi, M. (2017). Mortality due to cirrhosis, liver cancer, and disorders attributed to alcohol use: Global Burden of Disease in Brazil, 1990 and 2015. Rev Bras Epidemiol. 20 Suppl(Suppl 01):61-74. doi: 10.1590/1980-5497201700050006.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of computational chemistry, 30(16), 2785-2791.
Nas, J. S., Sanchez, A., Bullago, J.C., Fatalla, J.K., Gellecanao, Jr. F. (2021). Molecular interactions of cyanidin-3-glucoside with bacterial protein S modulate the virulence of selected pathogens in Caenorhabditis elegans. Asian J Biol Life Sci. 10(1):150-8. doi: 10.5530/ajbls.2021.10.22.
Porubsky, P. R., Meneely, K. M., Scott, E. E. (2008). Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J Biol Chem. 283(48):33698-707. doi: 10.1074/jbc.M805999200. 18818195.
Pu, Q. H., Shi, L., Yu, C. (2015). Time-dependent inhibition of CYP3A4 by gallic acid in human liver microsomes and recombinant systems. Xenobiotica. 45(3):213-7. doi: 10.3109/00498254.2014.973470.
Ramalingam, S., Babu, P. D. S., Periandy, S., & Fereyduni, E. (2011). Vibrational investigation, molecular orbital studies and molecular electrostatic potential map analysis on 3-chlorobenzoic acid using hybrid computational calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 84(1), 210-220.
Roe, D. R., & Cheatham III, T. E. (2013). PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. Journal of chemical theory and computation, 9(7), 3084-3095.
Rothman, R. B., Baumann, M. H., Prisinzano, T. E., & Newman, A. H. (2008). Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochemical pharmacology, 75(1), 2-16.
Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., et al. (2007). Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem. 282(19):14348-55. doi: 10.1074/jbc.M611692200.
Sarkar, D. (2021). Molecular Docking study to Identify Potent Fungal Metabolites as Inhibitors against SARS-CoV-2 Main Protease Enzyme. Int J Pharm Sci.12(2), b78-85 http://dx.doi.org/10.22376/ijpbs.2021.12.2.b78-85
Sarkar, D. (2022). In-silico research to screen various phytochemicals as potential therapeutics againstbeta glucan synthase enzyme from black fungus endangering COVID patients in India. Intern. J. Zool. Invest. 8(1): 320-337 https://doi.org/10.33745/ijzi.2022.v08i01.035
Sarkar, D., Ganguly, A. (2022). Molecular Docking Studies with Garlic Phytochemical Constituents To Inhibit The Human EGFR Protein For Lung Cancer Therapy. Int J Pharm Sci.13(2), B1-14 http://dx.doi.org/10.22376/Ijpbs.2022.13.2.b1-14.
Sarkar, D., Maiti, A. K. (2023). Virtual Screening and Molecular Docking Studies with Organosulfur and Flavonoid Compounds of Garlic Targeting the Estrogen Receptor Protein for the Therapy of Breast Cancer. 13(1), 2023, 49 https://doi.org/10.33263/BRIAC 131.049
Sarkar, D., Maiti, A. K., Rawaf, A., Babu, J. (2022). In silico Approach to Identify Potent Bioactive Compounds as Inhibitors against the Enoyl-acyl Carrier Protein (acp) Reductase Enzyme of Mycobacterium tuberculosis.12(5), 7023–7039. https://doi.org/10.33263/BRIAC 125.70237039
Sevrioukova, I. F. (2017). High-level production and properties of the cysteinedepleted cytochrome P450 3A4. Biochemistry. 56(24):3058-67. doi: 10.1021/acs.biochem.7b00334.
Sevrioukova, I. F., Poulos, T. L. (2013). Understanding the mechanism of cytochrome P450 3A4: Recent advances and remaining problems. Dalton Trans. 42(9):3116-26. doi: 10.1039/c2dt31833d.
Tsai, M. S., Chien, C. C., Lin, T. H., Liu, C.C., Liu, R. H., Su, H. L. (2015). Galangin prevents acute hepatorenal toxicity in novel propacetamol-induced acetaminophenoverdosed mice. J Med Food. 18(11):1187-97. doi: 10.1089/ jmf.2014.3328.
Wadapurkar, R. M., Shilpa, M. D., Katti, A. K. S., & Sulochana, M. B. (2018). In silico drug design for Staphylococcus aureus and development of host-pathogen interaction network. Informatics in Medicine Unlocked, 10, 58-70.
Yang, Y., Engkvist, O., Llinàs, A., Chen, H. (2012). Beyond size, ionization state, and lipophilicity: Influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. J Med Chem. 55(8):3667-77. doi: 10.1021/jm201548z.
Yoon, E., Babar, A., Choudhary, M., Kutner, M., Pyrsopoulos, N. (2016). Acetaminopheninduced hepatotoxicity: A comprehensive update. J Clin Transl Hepatol. 4(2):131-42. doi: 10.14218/JCTH.2015.00052.
How to cite this article
Sarkar, D. (2022). Molecular Docking of Putative Phytochemicals in Aqueous Moringa Oleifera leaf Extracts with Three Cytochrome P450 Enzyme Involved in Xenobiotic Metabolism. Science Archives, Vol. 3(4), 255-262. https://doi.org/10.47587/SA.2022.3403
Licence Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
